Pharmaceutical Compounder Assembly With Septa-Sealed Mixing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Manual mixing of multi-ingredient mixtures is inefficient, imprecise, and potentially hazardous, especially when dealing with pharmaceuticals, as it lacks precision and can be time-consuming, and poses risks with unsafe or hazardous ingredients.

Innovation Solution

A compounder apparatus with a manifold system that docks multiple reservoirs, extracts fluids, mixes them with a diluent in a controlled mixing chamber, and fills a destination reservoir, incorporating containment assemblies with elastomeric septa and variable-volume housing to ensure precise and safe compounding of pharmaceuticals.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual mixing of ingredients is performed, then flexibility and simplicity are maintained, but precision, efficiency, and safety deteriorate

Engineering Contradiction:
ImproveprecisionVSAvoidcomplexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The mixing system is segmented into distinct functional modules: a manifold system with multiple reservoir ports, individual reservoirs for each ingredient, a controlled mixing chamber, and a destination reservoir. This segmentation allows each component to perform its specific function with high precision while maintaining overall system manageability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an automated mixing apparatus as an intermediary between the ingredients and the final mixture. This intermediary device performs the mixing function with precise control over ingredient delivery and mixing parameters, eliminating the imprecision of manual mixing while containing the complexity within a dedicated system.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If automated mixing apparatus is used, then precision and safety improve, but device complexity increases

Engineering Contradiction:
ImprovesafetyVSAvoidcomplexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The hazardous mixing process is extracted from the manual operation domain and placed into a contained automated system. The mixing chamber provides physical containment of ingredients during mixing, and the automated delivery system eliminates direct human contact with potentially hazardous substances, improving safety while concentrating complexity within the automated apparatus.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The mixing apparatus is designed as a multi-functional system that can handle multiple ingredients from different reservoirs, perform precise metering and delivery, provide containment during mixing, and transfer the final product to a destination reservoir. This universality improves safety across different mixing scenarios while consolidating complexity into a single versatile platform.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If manual mixing is performed, then device complexity remains low, but productivity and efficiency deteriorate

Engineering Contradiction:
ImproveefficiencyVSAvoidcomplexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The automated mixing apparatus enables continuous operation through the manifold system that can sequentially or simultaneously access multiple reservoirs, continuously deliver ingredients to the mixing chamber, and transfer finished mixtures to destination reservoirs without interruption. This continuity dramatically improves productivity compared to manual mixing, with the complexity managed through automated control systems.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS11179688B2Compounder apparatus
Publication Date: 2021.11.23 DEKA PRODUCTS LP
  • US11179688B2 patent drawing
  • US11179688B2 patent drawing
  • US11179688B2 patent drawing

AI summary

A system including a containment assembly for enclosing a medication container may comprise a first housing portion or interface portion having a proximal end and a distal end. The interface portion may include a housing wall which defines a channel spanning from the proximal end to the distal end. The channel may be open at the proximal and distal end. The containment assembly may further comprise only two pierceable septa configured to form a barrier to the channel. The containment assembly may further comprise a variable-volume housing portion having a variable volume chamber. The variable-volume portion chamber of the variable-volume housing portion may be in fluid communication with the distal end of the channel.